235 related articles for article (PubMed ID: 26377541)
21. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
[TBL] [Abstract][Full Text] [Related]
22. Novel approach to target cancer stem cells for therapy.
Rajanna A
Med Hypotheses; 2016 Mar; 88():83-5. PubMed ID: 26611661
[TBL] [Abstract][Full Text] [Related]
23. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
24. Cancer stem cells in bladder cancer: a revisited and evolving concept.
Chan KS; Volkmer JP; Weissman I
Curr Opin Urol; 2010 Sep; 20(5):393-7. PubMed ID: 20657288
[TBL] [Abstract][Full Text] [Related]
25. Identification of tumor-initiating cells in a canine hepatocellular carcinoma cell line.
Michishita M; Ezaki S; Ogihara K; Naya Y; Azakami D; Nakagawa T; Sasaki N; Arai T; Shida T; Takahashi K
Res Vet Sci; 2014 Apr; 96(2):315-22. PubMed ID: 24534130
[TBL] [Abstract][Full Text] [Related]
26. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.
Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S
Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785
[TBL] [Abstract][Full Text] [Related]
27. Biology and clinical implications of CD133(+) liver cancer stem cells.
Ma S
Exp Cell Res; 2013 Jan; 319(2):126-32. PubMed ID: 22999864
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines.
Michishita M; Otsuka A; Nakahira R; Nakagawa T; Sasaki N; Arai T; Takahashi K
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):73-81. PubMed ID: 24041801
[TBL] [Abstract][Full Text] [Related]
29. Thyroid tumor-initiating cells: increasing evidence and opportunities for anticancer therapy (review).
Gao YJ; Li B; Wu XY; Cui J; Han JK
Oncol Rep; 2014 Mar; 31(3):1035-42. PubMed ID: 24424445
[TBL] [Abstract][Full Text] [Related]
30. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
[TBL] [Abstract][Full Text] [Related]
31. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
32. Pivotal role of CD38 biomarker in combination with CD24, EpCAM, and ALDH for identification of H460 derived lung cancer stem cells.
Karimi-Busheri F; Zadorozhny V; Li T; Lin H; Shawler DL; Fakhrai H
J Stem Cells; 2011; 6(1):9-20. PubMed ID: 22997842
[TBL] [Abstract][Full Text] [Related]
33. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids.
Oktem G; Sercan O; Guven U; Uslu R; Uysal A; Goksel G; Ayla S; Bilir A
Oncol Rep; 2014 Aug; 32(2):641-9. PubMed ID: 24927163
[TBL] [Abstract][Full Text] [Related]
34. Enrichment and characterization of cancer stem cells from a human non-small cell lung cancer cell line.
Zhao C; Setrerrahmane S; Xu H
Oncol Rep; 2015 Oct; 34(4):2126-32. PubMed ID: 26239272
[TBL] [Abstract][Full Text] [Related]
35. Limits of CD133 as a marker of glioma self-renewing cells.
Clément V; Dutoit V; Marino D; Dietrich PY; Radovanovic I
Int J Cancer; 2009 Jul; 125(1):244-8. PubMed ID: 19350631
[TBL] [Abstract][Full Text] [Related]
36. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
[TBL] [Abstract][Full Text] [Related]
37. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
Ma L; Lai D; Liu T; Cheng W; Guo L
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
[TBL] [Abstract][Full Text] [Related]
38. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
39. Label-free selection and enrichment of liver cancer stem cells by surface niches build up with polyelectrolyte multilayer films.
Lee IC; Chang JF
Colloids Surf B Biointerfaces; 2015 Jan; 125():120-6. PubMed ID: 25461919
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]